Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: Pain has highest priority

被引:214
作者
Heiberg, T
Kvien, TK
机构
[1] Univ Oslo, Dept Rheumatol, Diakonhjemmet Hosp, N-0319 Oslo, Norway
[2] Ulleval Univ Hosp, Oslo, Norway
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2002年 / 47卷 / 04期
关键词
preferences; rheumatoid arthritis; pain; health status measure; health care;
D O I
10.1002/art.10515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine preferences for improved health in patients with rheumatoid arthritis (RA). Methods. A survey was mailed to patients with RA enrolled in a county-based register. The questionnaire comprised a variety of health status measures (Medical Outcome Study Short Form-36, Arthritis Impact Measurement Scales 2 [AIMS2], Modified Health Assessment Questionnaire, and visual analog scale for pain and fatigue). The patients were asked to check 3 of 12 areas in which they would most like to see improvement (item 60 AIMS2). The number of respondents was 1,024 (mean age/disease duration 63.4/12.7 years, 78.7% female). Results. Pain was the preferred area for improvement in all subgroups of patients. Preference for improvement in pain was associated with lower age, higher levels of perceived pain, and lower scores for self efficacy related to pain. One-third of the patients with this preference did not report use of pain-relieving medication. Conclusion. Pain is the area of health in which almost 70% of the patients would like to see improvement. This study suggests that more attention should be paid to the examination of patient preferences for improvement in health.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 42 条
[1]  
Archenholtz B, 1997, J RHEUMATOL, V24, P1370
[2]  
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[3]  
BANDURA A, 1986, SOCIAL FDN THOUGHT A
[4]   Concordant and discrepant views of patients' physical functioning [J].
Berkanovic, E ;
Hurwicz, ML ;
Lachenbruch, PA .
ARTHRITIS CARE AND RESEARCH, 1995, 8 (02) :94-101
[5]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[6]   Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study [J].
Brekke, M ;
Hjortdahl, P ;
Kvien, TK .
RHEUMATOLOGY, 2001, 40 (04) :387-392
[7]  
BREKKE M, IN PRESS ARTHRITIS R
[8]  
BUESCHER KL, 1991, J RHEUMATOL, V18, P968
[9]   Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison [J].
Emery, P ;
Zeidler, H ;
Kvien, TK ;
Guslandi, M ;
Naudin, R ;
Stead, H ;
Verburg, KM ;
Isakson, PC ;
Hubbard, RC ;
Geis, GS .
LANCET, 1999, 354 (9196) :2106-2111
[10]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145